Factsheet data is now cached locally - if you have visited a page you can now view it offline!
Are you a harm reduction organisation using TripSit? Let us know about you!
Zopiclone
Basic Information
Summary
A nonbenzodiazepine sedative sleep aid (Z-drug), which can have hallucinogenic effects if taken while awake. Often causes users to have a metallic taste in the mouth for ~12h. Has been reported in some cases to cause certain users to black out, redose excessively and undertake dangerous activities such as driving.
Depressant
Depressants are drugs which reduce arousal and stimulation in the user, characterised by a depressing of mental and physical functions.
Read more on TripSit Wiki...Habit-forming
These drugs pose a higher risk of causing habit forming behaviour, take particular care with the amount and frequency they are taken.
Read more on TripSit Wiki...Common
Common drugs are those which are well known and widely used among the drug community. This doesn't necessarily mean they are safe, but it usually comes with a longer relative history of use in humans with which to establish a safety profile.
Dose
| Oral | |
|---|---|
| Threshold | 3.5mg |
| Light | 3.5-5mg |
| Common | 5-7.5mg |
| Strong | 7.5-15mg |
| Heavy | 15-22.5mg |
Duration
| All ROAs | |
|---|---|
| Onset | 15 minutes |
| Duration | 3.5-9 hours |
| After-effects | 1-12 hours |
Effects
Lethargy, tiredness, a dreamlike state while awake, can induce heavy sleep.
Aliases
imovane
zimovane
Contraindictions
Liver disease, myasthenia gravis, severe chronic bronchitis, emphysema, sleep apnea, thyroid gland abnormalities, trimipramine, caffeine, alcohol, erythromycin, itraconazole, rifampicin, phenytoin, carbamazepine, ketoconazole, sulfaphenazole, and nefazodone
Chemistry
IUPAC: (RS)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate | Formula: C17H17ClN6O3 | Molecular Mass: 388.808 g/mol
Pharmacology
GABA-A receptor positive allosteric modulator; Benzodiazepine receptor agonist
Pharmacokinetics
Protein Binding: 45 - 80% | Metabolism: various cytochrome P450 liver enzymes | Excretion: respiration (~50%) and urine (7 - 10 %)
Legal
Australia: Prescription Only (S4) | United Kingdom: Controlled Drug (POM) | United States: Schedule IV
Interactions
No interaction information for Zopiclone